Primed polymorphonuclear leukocytes constitute a possible link between inflammation and oxidative stress in hyperlipidemic patients.

[1]  N. Vaziri,et al.  Spontaneous leukocyte activation and oxygen-free radical generation in end-stage renal disease. , 2007, Kidney international.

[2]  S. Sela,et al.  [Polymorphonuclear leukocyte priming and counts are in correlation with blood pressure parameters]. , 2006, Harefuah.

[3]  S. Sela,et al.  Primed peripheral polymorphonuclear leukocyte: a culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease. , 2005, Journal of the American Society of Nephrology : JASN.

[4]  E. Sato,et al.  Enhanced oxidative stress in neutrophils from hyperlipidemic guinea pig. , 2005, Atherosclerosis.

[5]  T. Imaizumi,et al.  Polymorphonuclear Leukocytes May Impair Endothelial Function: Results of Crossover Randomized Study of Lipid-Lowering Therapies , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[6]  A. Lumsden,et al.  Defensins and cathelicidins: Neutrophil peptides with roles in inflammation, hyperlipidemia and atherosclerosis , 2005, Journal of cellular and molecular medicine.

[7]  P. Stenvinkel,et al.  Inflammation and oxidative stress in ESRD--the role of myeloperoxidase. , 2004, Journal of nephrology.

[8]  L. Kosmiski,et al.  Acute Pancreatitis in HIV-Infected Patients: Are Etiologies Changing Since the Introduction of Protease Inhibitor Therapy? , 2003, Pancreas.

[9]  P. Stenvinkel,et al.  A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients. , 2003, Kidney international. Supplement.

[10]  N. Hollenberg,et al.  Glomerular hemodynamics and the renin-angiotensin system in patients with type 1 diabetes mellitus. , 2003, Kidney international.

[11]  J. Wetzels,et al.  Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  S. Sela,et al.  The involvement of peripheral polymorphonuclear leukocytes in the oxidative stress and inflammation among cigarette smokers. , 2002, The Israel Medical Association journal : IMAJ.

[13]  M. Rosenfeld,et al.  Chlamydia pneumoniae and Hyperlipidemia Are Co-Risk Factors for Atherosclerosis: Infection Prior to Induction of Hyperlipidemia Does Not Accelerate Development of Atherosclerotic Lesions in C57BL/6J Mice , 2002, Infection and Immunity.

[14]  T. Rohn,et al.  Neutrophil priming in host defense: role of oxidants as priming agents. , 2002, Antioxidants & redox signaling.

[15]  E J Topol,et al.  Association between myeloperoxidase levels and risk of coronary artery disease. , 2001, JAMA.

[16]  K. Chien,et al.  Peripheral differential leukocyte counts in humans vary with hyperlipidemia, smoking, and body mass index , 2001, Lipids.

[17]  S. Sela,et al.  Involvement of Peripheral Polymorphonuclear Leukocytes in Oxidative Stress and Inflammation in Type 2 Diabetic Patients , 2001 .

[18]  A. Carr,et al.  Oxidation of LDL by myeloperoxidase and reactive nitrogen species: reaction pathways and antioxidant protection. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[19]  E. Bey,et al.  In vitro knockout of human p47phox blocks superoxide anion production and LDL oxidation by activated human monocytes. , 2000, Journal of lipid research.

[20]  S. Sela,et al.  Participation of peripheral polymorphonuclear leukocytes in the oxidative stress and inflammation in patients with essential hypertension. , 1997, American journal of hypertension.

[21]  D. Discher,et al.  Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V. , 1996, Blood.

[22]  R. Maranhão,et al.  Evaluation of oxidative stress in patients with hyperlipidemia. , 1995, Atherosclerosis.

[23]  L. Mcphail,et al.  Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. Evidence for increased activity of the superoxide-producing enzyme , 1984, The Journal of experimental medicine.

[24]  D. Hunninghake,et al.  INCREASED LEUCOCYTE OXIDATIVE METABOLISM IN HYPERLIPOPROTEINAEMIA , 1982, The Lancet.

[25]  C. McCall,et al.  Human toxic neutrophils. 3. Metabolic characteristics. , 1973, The Journal of infectious diseases.

[26]  V. Faber,et al.  THE TOXICITY OF CADMIUM , 1964, Lancet.